Results 231 to 240 of about 527,379 (343)
Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome [PDF]
, 2018 Magdalena Pirowska +7 more
openalex +1 more source
Advanced Science, EarlyView.Hyaluronic acid‐modified bimetallic peroxide nanocomposites (MgO2‐CuO2@HA) are designed for synergistic tumor therapy. The nanocomposites release Mg2+, H2O2, and Cu2+ in tumor cells, induce cuproptosis via Cu+‐mediated protein aggregation, and activate pyroptosis through caspase‐1/gasdermin D pathways for inducing immunogenic cell death, collectively ...
Guanting He +8 more
wiley +1 more source
Interleukin 12/23 and interleukin 23 inhibitors for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. [PDF]
Ann GastroenterolSawaf B +14 more
europepmc +1 more source
Interleukin-23 Mediates Osteoclastogenesis in Collagen-Induced Arthritis by Modulating MicroRNA-223. [PDF]
Int J Mol Sci, 2022 Chen SY +8 more
europepmc +1 more source
The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
, 2020 Alexander Egeberg +4 more
openalex +1 more source
Cleavage‐Resistant CYLD Protects Against Autoimmune Hepatitis
Advanced Science, EarlyView.Proteolytic cleavage of the deubiquitinase CYLD emerges as a critical driver of autoimmune hepatitis. TNFα‐induced CYLD loss in macrophages amplifies S100A9‐triggered MAPK activation, leading to excessive chemokine production and hepatic inflammation. Pharmacological inhibition of MEK signaling effectively attenuates experimental disease, highlighting ...
Han Liu +13 more
wiley +1 more source
The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: A case series. [PDF]
JAAD Case Rep, 2022 Ch'en PY +3 more
europepmc +1 more source